{"id":45614,"date":"2024-10-23T07:18:00","date_gmt":"2024-10-23T05:18:00","guid":{"rendered":"http:\/\/kutsekoda.ee\/?p=45614"},"modified":"2024-10-23T07:44:48","modified_gmt":"2024-10-23T05:44:48","slug":"oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu","status":"publish","type":"post","link":"https:\/\/kutsekoda.ee\/ru\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/","title":{"rendered":"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu"},"content":{"rendered":"\n<p><strong>Eesti farmaatsiat\u00f6\u00f6stusel on suur potentsiaal l\u00e4hik\u00fcmnendil teadus-arendustegevust ja tootmist laiendada. Praegu suhteliselt v\u00e4ikese t\u00f6\u00f6tajate arvuga sektoris v\u00f5ib see t\u00e4hendada 70% h\u00f5ive kasvu, selgub v\u00e4rskest Kutsekoja <a href=\"https:\/\/uuringud.oska.kutsekoda.ee\/uuringud\/farmaatsia\">OSKA uuringust<\/a>.<\/strong><\/p>\n\n\n\n<!--more-->\n\n\n\n<p>Eestis on t\u00e4rkamas maailmatasemel ravimiarendus. Hoogustunud on digimeditsiini, biotehnoloogia, suurandmete ja geneetiliste andmete kasutamine ning koos sellega on ettev\u00f5tted hakanud tegema uute arenduste ja tootmise laiendamise plaane.<\/p>\n\n\n\n<p>\u201eFarmaatsiat\u00f6\u00f6stusettev\u00f5tted paistavad silma k\u00f5rgtehnoloogilisuse, innovaatilisuse ja ekspordile orienteeritusega, mis t\u00e4hendab, et k\u00f5ik eduka t\u00f6\u00f6stusvaldkonna kriteeriumid on t\u00e4idetud,\u201c \u00fctles OSKA uuringujuht <strong>Riina Tilk<\/strong>. \u201eSamas on Eesti ravimit\u00f6\u00f6stusel keerukas konkureerida muu maailmaga toodangu hindade ja mahtude osas. Kohalik t\u00f6\u00f6j\u00f5ud ei ole enam odav ning tootmise kulusisendid on k\u00f5rged, mis teeb Eestist v\u00f5rreldes mitmete teiste riikidega kallima tootmiskeskkonna.\u201c<\/p>\n\n\n\n<p>Riina Tilga s\u00f5nul n\u00e4evad eksperdid, et Eestile v\u00f5iks konkurentsieelise anda teenusepakkumine ravimite arendusprotsessi kitsamates etappides ning keskendumine keerulisematele ja teadmusmahukamatele tegevustele.&nbsp; N\u00e4iteks saab arendada toimeaineid, mille ravimvormi v\u00e4ljat\u00f6\u00f6tamine, registreerimine ja turustamine j\u00e4\u00e4b v\u00e4lismaistele koost\u00f6\u00f6partneritele. Samuti saab s\u00fcnteesida uusi toimeaineid, uurida nende omadusi v\u00f5i pakkuda laboriteenuseid ning kvaliteedi- ja stabiilsusuuringuid rahvusvahelistele farmaatsiafirmadele.<\/p>\n\n\n\n<p><strong>T\u00f6\u00f6j\u00f5udu on juurde vaja<\/strong><\/p>\n\n\n\n<p>OSKA uuringust selgub, et 2023. aasta seisuga t\u00f6\u00f6tas Eesti&nbsp; farmaatsiat\u00f6\u00f6stusega seotud p\u00f5hikutsealadel u 600 inimest. Teadus- ja arendustegevuse ning tootmise laienedes v\u00f5ib h\u00f5ive j\u00e4rgmise k\u00fcmne aasta jooksul kasvatada 70%, arvuliselt t\u00e4hendab see u 400 inimese lisandumist. Lisaks on vaja u 135 t\u00f6\u00f6tajat v\u00f5imalike pensionile j\u00e4\u00e4jate asendamiseks.<\/p>\n\n\n\n<p>Kasvuvajadust prognoositakse k\u00f5igil p\u00f5hikutsealadel. Suurim on t\u00e4iendava t\u00f6\u00f6j\u00f5u vajadus oskust\u00f6\u00f6tajate kategoorias. Juba praegu napib kutseharidusega ja heade k\u00e4eliste oskustega laborante. \u201eEestis on v\u00f5rreldes muu maailmaga m\u00e4rkimisv\u00e4\u00e4rselt rohkem magistrikraadiga laborit\u00f6\u00f6tajaid, mis viitab t\u00f6\u00f6j\u00f5uressursi ebaefektiivsele kasutamisele ning soodustab t\u00f6\u00f6tajate voolavust,\u201c \u00fctles OSKA anal\u00fc\u00fctik <strong>Elin-K\u00fclliki Kruusmaa<\/strong>.<\/p>\n\n\n\n<p>Ta t\u00f5i v\u00e4lja, et laborandi\u00f5pe on praegu tugevalt regionaalne, piirdudes vaid Ida-Virumaa Kutsehariduskeskusega, kus \u00f5ppet\u00f6\u00f6 toimub osaliselt vene keeles ning keskendub rohkem p\u00f5levkivit\u00f6\u00f6stusele.<\/p>\n\n\n\n<p>OSKA ettepanek on leida t\u00f6\u00f6andjate ja koolide koost\u00f6\u00f6s lahendused kutseharidusega laborantide \u00f5ppev\u00f5imaluste laiendamiseks. Seda enam, et laborit\u00f6\u00f6 universaalsete baasoskustega inimesi vajatakse ka teistes valdkondades \u2013 nt tervishoiusektoris, keskkonna valdkonnas, p\u00f5llumajandus- ja toiduainet\u00f6\u00f6stuses, teimimise ja anal\u00fc\u00fcsiteenuste valdkonnas jne.<\/p>\n\n\n\n<p><strong>Spetsiifilisi oskusi napib<\/strong><\/p>\n\n\n\n<p>Kuigi farmaatsiat\u00f6\u00f6stusele sobiva k\u00f5rgharidusliku ettevalmistusega inimesi on Eestis piisavalt, on siin murekoht spetsiifiliste oskuste puuduj\u00e4\u00e4k. \u201eVajaka on farmaatsiateadmistega ning ravimiarenduse ja \u2011tootmise tervikvaatega spetsialistidest. Ravimiteaduse alast teadmist saab omandada \u00fcksnes Tartu \u00dclikooli proviisori \u00f5ppes, ent \u00f5pe on apteegikeskne ning farmaatsiat\u00f6\u00f6stusesse j\u00f5uab eriala l\u00f5petanuid v\u00e4he,\u201c r\u00e4\u00e4kis Riina Tilk.<\/p>\n\n\n\n<p>OSKA soovitus on kujundada \u00f5ppekava paindlikumaks 3+2 bakalaureuse ja magistri\u00f5ppeks, kus magistriastmes oleks v\u00f5imalik spetsialiseeruda ka ravimiarendusele ning kuhu v\u00f5ivad kandideerida ka teiste loodusteaduste erialade l\u00f5petajad.<\/p>\n\n\n\n<p>Nagu muudes t\u00f6\u00f6stusvaldkondades, nii ka farmaatsiat\u00f6\u00f6stuses tuntakse puudust inseneridest. Uuringus t\u00f5detakse, et keemia ja sellega seotud erialade \u00f5petamine Eesti k\u00f5rgkoolides on pigem akadeemiline ja teadusele orienteeritud, j\u00e4ttes t\u00e4helepanuta t\u00f6\u00f6stusinseneeria ja inseneriteaduse praktilise rakenduse aspektid. Seet\u00f5ttu on keemia- ja farmaatsiat\u00f6\u00f6stusettev\u00f5tted sageli sunnitud inseneeriaga seotud kompetentsi v\u00e4lismaalt sisse ostma.<\/p>\n\n\n\n<p>Tutvu OSKA uuringuga \u201eTulevikuvaade t\u00f6\u00f6j\u00f5u- ja oskuste vajadusele: farmaatsiat\u00f6\u00f6stus\u201c <a href=\"https:\/\/uuringud.oska.kutsekoda.ee\/uuringud\/farmaatsia\">SIIN<\/a>.<\/p>\n\n\n\n<p>Oskuste ning t\u00f6\u00f6j\u00f5uvajaduse seire- ja prognoosis\u00fcsteemi OSKA uuringute koostamist korraldab SA&nbsp;Kutsekoda Euroopa Sotsiaalfondi vahenditest.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eesti farmaatsiat\u00f6\u00f6stusel on suur potentsiaal l\u00e4hik\u00fcmnendil teadus-arendustegevust ja tootmist laiendada. Praegu suhteliselt v\u00e4ikese t\u00f6\u00f6tajate arvuga sektoris v\u00f5ib see t\u00e4hendada 70% h\u00f5ive kasvu, selgub v\u00e4rskest Kutsekoja OSKA uuringust.<\/p>\n","protected":false},"author":14,"featured_media":45616,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","footnotes":""},"categories":[1163,1041],"tags":[],"class_list":["post-45614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oska","category-uus"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu - Kutsekoda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/\" \/>\n<meta property=\"og:locale\" content=\"ru_RU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu - Kutsekoda\" \/>\n<meta property=\"og:description\" content=\"Eesti farmaatsiat\u00f6\u00f6stusel on suur potentsiaal l\u00e4hik\u00fcmnendil teadus-arendustegevust ja tootmist laiendada. Praegu suhteliselt v\u00e4ikese t\u00f6\u00f6tajate arvuga sektoris v\u00f5ib see t\u00e4hendada 70% h\u00f5ive kasvu, selgub v\u00e4rskest Kutsekoja OSKA uuringust.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/\" \/>\n<meta property=\"og:site_name\" content=\"Kutsekoda\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-23T05:18:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-23T05:44:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1442\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Siret Trull\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c\" \/>\n\t<meta name=\"twitter:data1\" content=\"Siret Trull\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u043c\u0438\u043d\u0443\u0442\u044b\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/\"},\"author\":{\"name\":\"Siret Trull\",\"@id\":\"https:\/\/kutsekoda.ee\/#\/schema\/person\/ec98503b04903f902c85d1f97d38e02f\"},\"headline\":\"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu\",\"datePublished\":\"2024-10-23T05:18:00+00:00\",\"dateModified\":\"2024-10-23T05:44:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/\"},\"wordCount\":569,\"image\":{\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg\",\"articleSection\":[\"OSKA\",\"Uus\"],\"inLanguage\":\"ru-RU\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/\",\"url\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/\",\"name\":\"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu - Kutsekoda\",\"isPartOf\":{\"@id\":\"https:\/\/kutsekoda.ee\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg\",\"datePublished\":\"2024-10-23T05:18:00+00:00\",\"dateModified\":\"2024-10-23T05:44:48+00:00\",\"author\":{\"@id\":\"https:\/\/kutsekoda.ee\/#\/schema\/person\/ec98503b04903f902c85d1f97d38e02f\"},\"breadcrumb\":{\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#breadcrumb\"},\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage\",\"url\":\"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg\",\"contentUrl\":\"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg\",\"width\":2560,\"height\":1442,\"caption\":\"Foto: J. Molner Company\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Esileht\",\"item\":\"https:\/\/kutsekoda.ee\/ru\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kutsekoda.ee\/#website\",\"url\":\"https:\/\/kutsekoda.ee\/\",\"name\":\"Kutsekoda\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kutsekoda.ee\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ru-RU\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/kutsekoda.ee\/#\/schema\/person\/ec98503b04903f902c85d1f97d38e02f\",\"name\":\"Siret Trull\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7dfdf74a85f4a3ad19f3552e321ae204b1e6ce69d74eda7ae3c2e885908901f6?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7dfdf74a85f4a3ad19f3552e321ae204b1e6ce69d74eda7ae3c2e885908901f6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7dfdf74a85f4a3ad19f3552e321ae204b1e6ce69d74eda7ae3c2e885908901f6?s=96&d=mm&r=g\",\"caption\":\"Siret Trull\"},\"description\":\"ESF projekti kommunikatsioonijuht\",\"url\":\"https:\/\/kutsekoda.ee\/ru\/author\/sirett\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu - Kutsekoda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/","og_locale":"ru_RU","og_type":"article","og_title":"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu - Kutsekoda","og_description":"Eesti farmaatsiat\u00f6\u00f6stusel on suur potentsiaal l\u00e4hik\u00fcmnendil teadus-arendustegevust ja tootmist laiendada. Praegu suhteliselt v\u00e4ikese t\u00f6\u00f6tajate arvuga sektoris v\u00f5ib see t\u00e4hendada 70% h\u00f5ive kasvu, selgub v\u00e4rskest Kutsekoja OSKA uuringust.","og_url":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/","og_site_name":"Kutsekoda","article_published_time":"2024-10-23T05:18:00+00:00","article_modified_time":"2024-10-23T05:44:48+00:00","og_image":[{"width":2560,"height":1442,"url":"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg","type":"image\/jpeg"}],"author":"Siret Trull","twitter_card":"summary_large_image","twitter_misc":{"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c":"Siret Trull","\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f":"3 \u043c\u0438\u043d\u0443\u0442\u044b"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#article","isPartOf":{"@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/"},"author":{"name":"Siret Trull","@id":"https:\/\/kutsekoda.ee\/#\/schema\/person\/ec98503b04903f902c85d1f97d38e02f"},"headline":"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu","datePublished":"2024-10-23T05:18:00+00:00","dateModified":"2024-10-23T05:44:48+00:00","mainEntityOfPage":{"@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/"},"wordCount":569,"image":{"@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage"},"thumbnailUrl":"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg","articleSection":["OSKA","Uus"],"inLanguage":"ru-RU"},{"@type":"WebPage","@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/","url":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/","name":"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu - Kutsekoda","isPartOf":{"@id":"https:\/\/kutsekoda.ee\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage"},"image":{"@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage"},"thumbnailUrl":"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg","datePublished":"2024-10-23T05:18:00+00:00","dateModified":"2024-10-23T05:44:48+00:00","author":{"@id":"https:\/\/kutsekoda.ee\/#\/schema\/person\/ec98503b04903f902c85d1f97d38e02f"},"breadcrumb":{"@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#breadcrumb"},"inLanguage":"ru-RU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/"]}]},{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#primaryimage","url":"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg","contentUrl":"https:\/\/kutsekoda.ee\/wp-content\/uploads\/2024\/10\/J_Molner_1-scaled-e1729592226636.jpg","width":2560,"height":1442,"caption":"Foto: J. Molner Company"},{"@type":"BreadcrumbList","@id":"https:\/\/kutsekoda.ee\/oska-prognoosib-vaikese-hoivega-farmaatsiatoostuses-olulist-kasvu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Esileht","item":"https:\/\/kutsekoda.ee\/ru\/"},{"@type":"ListItem","position":2,"name":"OSKA prognoosib v\u00e4ikese h\u00f5ivega farmaatsiat\u00f6\u00f6stuses olulist kasvu"}]},{"@type":"WebSite","@id":"https:\/\/kutsekoda.ee\/#website","url":"https:\/\/kutsekoda.ee\/","name":"Kutsekoda","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kutsekoda.ee\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ru-RU"},{"@type":"Person","@id":"https:\/\/kutsekoda.ee\/#\/schema\/person\/ec98503b04903f902c85d1f97d38e02f","name":"Siret Trull","image":{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/secure.gravatar.com\/avatar\/7dfdf74a85f4a3ad19f3552e321ae204b1e6ce69d74eda7ae3c2e885908901f6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7dfdf74a85f4a3ad19f3552e321ae204b1e6ce69d74eda7ae3c2e885908901f6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7dfdf74a85f4a3ad19f3552e321ae204b1e6ce69d74eda7ae3c2e885908901f6?s=96&d=mm&r=g","caption":"Siret Trull"},"description":"ESF projekti kommunikatsioonijuht","url":"https:\/\/kutsekoda.ee\/ru\/author\/sirett\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-22 10:05:33","action":"category","newStatus":"draft","terms":[0],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/posts\/45614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/comments?post=45614"}],"version-history":[{"count":4,"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/posts\/45614\/revisions"}],"predecessor-version":[{"id":45621,"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/posts\/45614\/revisions\/45621"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/media\/45616"}],"wp:attachment":[{"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/media?parent=45614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/categories?post=45614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kutsekoda.ee\/ru\/wp-json\/wp\/v2\/tags?post=45614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}